课题基金 / 基金详情

Vaccine Studies in HIV-infected Subjects

Vaccine Studies in HIV-infected Subjects
HIV 感染者的疫苗研究
批准号：
8148436
负责人：
Barney Graham
金额：
$55.53万
依托单位：
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/8148436
关键词：
DNAEducational MaterialsEligibility DeterminationEnrollmentGoalsHIV-1Immune responseIndividualInfectionMedication ManagementPhaseRecruitment ActivityScreening ResultTherapeuticTherapeutic StudiesVaccines

项目摘要

项目成果

Barney Graham的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
VRC 100 was designed to recruit and screen HIV-infected subjects for therapeutic HIV vaccines, as well as other vaccines to be developed for use in HIV-infected individuals. The results of this screening study were used to determine if the subject met eligibility requirements for participation a vaccine study. Educational materials on vaccines were reviewed with and provided to subjects before enrollment into a vaccine study. VRC 101 was the first Phase I therapeutic study of two candidate HIV-1 vaccines developed by VRC and administered in a prime-boost regimen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Immune Responses to RSV infection in Mice
Rapid Development of Vaccines for Emerging Viruses
Factors Contributing To Immune-Enhanced Disease In The Pathogenesis of RSV
Vectors and Methods to Increase Immunogenicity during DNA Vaccination
海外基金